- This event has passed.
Tablet and Capsule Technology: Formulation and Troubleshooting
April 5, 2022 - April 7, 2022
This is an in-depth course with hands on experience intended for product development scientists and technologists and support groups concerned with the development, designing and processing of tablets and similar oral products.
Register – Use code FE22 – $100 discount off the posted current tuition/price.
Dates: April 5-7, 2022
Time: 8:30am-5:30pm EDT
Location: Cleveland, OH
Who Should Attend?
The material will be presented in such a way as to be of value to a varying level of expertise. This course will especially benefit those in:
- Formulation Development
- Quality Assurance (Formulation Development Support staff)
- Research and Development
- Regulatory Affairs (CMC Writers)
- Manufacturing /Production
An Accredited Classroom Training Course in Collaboration with Federal Equipment Company and Techceuticals, the training division of Federal Equipment Company
Federal Equipment Company has been supplying used process equipment & industrial machinery since 1957. Federal Equipment Company specializes in processing and packaging equipment and stock 1000’s of pieces of equipment covering 275 distinct categories.
Solid oral dosage forms, or more commonly tablets, are the most common type of dosage form for pharmaceutical and nutraceutical products. Yet, what may appear to the eye as just a very simple tablet can be fraught with hidden complexities. There are many different ways to manufacture these products starting with the appropriate selection of excipients all the way through the production of the finished product. Ultimately, the successful production of a tablet is dependent upon the knowledge and expertise of the developers, formulators, and production staff.
In addition to the process for material placement extensively described, participants will gain experience through hand on laboratory projects/demonstrations. By doing so, the participant is given both the knowledge and experience to choose both ingredients and process to meet the challenges in formulation development. The experimental planning process is reviewed with examples to develop and verify the design space and justify performance. This enables the participants to make statistically sound and safe process and formulation decisions. The program concludes with key aspects of scale Up and technical transfers and risk elimination. Examples, evaluation, problem-solving and regulatory constraints are discussed at each stage.
Formal sessions of the course are supplemented with demonstrations of relevant machinery including Tablet Presses, High Shear Mixers / Granulators, Fluid Bed Dryers/Processors, Mills, Mixers, Roller Compactors and Coaters/Coating Pans.
Please note schedule: April 5th and 6th – 8:30am-5:00pm and April 7th 8:30am-12:00pm EDT. A Continental Breakfast at 8:00am, a one-hour lunch and two 15-minute breaks are planned each day.
PLEASE NOTE CfPA’S HEALTH & SAFETY POLICY:
Our staff and attendee’s health and safety are always a top priority. All registrants attending this event will be required to show proof of full COVID-19 vaccination.
More information can be found in our FAQs.
|Dr. Cecil W. Propst, Managing Director, Propst Consulting Services|
Dr. Cecil W. Propst is Managing Director at Propst Consulting Services, a formulation, and engineering support LLC located in Norton Shores MI. He was Director of R&D (Grand Haven site) at SPI Pharma until 2015. He served as Director of Quality Assurance and Technical Services at Fleming and Company, and before that, President of Manufacturing Chemists. His duties included system design, product and process development and regulatory affairs. Previously, he served as cGMP Facilities Director for the University of Maryland at Baltimore, in connection with the University’s SUPAC contract with the FDA. Dr. Propst also served as Director of Technical Development for Stellar Manufacturing; Director of Quality Compliance for SmithKline Beecham; Director, Quality Assurance for Norcliff Thayer (a Revlon Company); and Group Leader/Product Development and Manager/Quality Control for Lewis Howe Company. He serves as a consultant in the area of product development and process investigations for the chemical, diagnostic, food, engineering and beverage industries.
|Dilip Parikh, President and CEO, DPharma Group Inc.|
Dilip M. Parikh is the President and CEO of DPharma Group Inc., a Pharmaceutical Technology consulting organization. He has over 45 years of varied experience in the pharmaceutical industry which ranges from product development, manufacturing, regulatory affairs, and operational & executive management, gained at Sandoz (Canada), McNeil and Ortho Pharmaceutical (Johnson & Johnson family of companies) in Canada and the US, and other pharmaceutical companies. He is the Editor of the book Handbook of Pharmaceutical Granulation Technology (1997, Marcel Dekker, NY). Second edition published in September 2005 (Taylor and Francis, Publisher); Third edition in 2009 (Taylor and Francis, Publisher) and the Fourth edition in 2021 (CRC Press, Publisher) and the author of “How to Optimize Fluid Bed Processing Technology” (2007, Academic Press Elsevier, Publisher).
Joel Light, Principal Scientist at TEAM Pharma, a formulation development, clinical supply, and contract manufacturing company
John Ciasulli, VP Sales/GM Frewitt Corp – Guest Speaker
Jason Belz, Regional Sales Manager Syntegon Pharm Tech/Bosch – Guest Speaker Jim Hahn, VP Thomas Engineering/IMA – Guest Speaker Jesus Lopez, Federal Equipment, Lab Manager
PLEASE NOTE: Participants must make their own reservations; the cost of hotel accommodation is not included in the course fee. Final hotel information will be emailed to you in your confirmation package approximately 3 weeks prior to the course start date.